Erina Koga‐Yamakawa

A novel systemically administered toll‐like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

Amy L. Adlard, Simon J. Dovedi, Brian A. Telfer et al. · International Journal of Cancer · 2014 · 50 citations · Full text

Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy

Simon J. Dovedi, Amy L. Adlard, Yosuke Ota et al. · Oncotarget · 2016 · 30 citations · Full text

Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies

Alexander I. Spira, Aaron R. Hansen, Wael A. Harb et al. · Targeted Oncology · 2021 · 29 citations · Full text

Intratracheal and oral administration of SM‐276001: A selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer

Erina Koga‐Yamakawa, Simon J. Dovedi, Masashi Murata et al. · International Journal of Cancer · 2012 · 27 citations · Full text

Topical Tlr7 Agonists, Immunology, Immunoediting +20

TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice

Erina Koga‐Yamakawa, Masashi Murata, Simon J. Dovedi et al. · Cancer Immunology Immunotherapy · 2015 · 24 citations · Full text

Tlr7 Tolerance, Cancer Immunosurveillance, Autoimmune Disease +14